Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 19 | 2024 | 17564 | 1.090 |
Why?
|
Encephalomyelitis, Eastern Equine | 1 | 2020 | 14 | 0.730 |
Why?
|
Relapsing Fever | 1 | 2020 | 25 | 0.720 |
Why?
|
Borrelia | 1 | 2020 | 66 | 0.700 |
Why?
|
AIDS Dementia Complex | 2 | 2019 | 154 | 0.680 |
Why?
|
RNA, Viral | 4 | 2021 | 2865 | 0.660 |
Why?
|
Cerebral Infarction | 2 | 2020 | 983 | 0.620 |
Why?
|
Muscle Weakness | 2 | 2022 | 415 | 0.610 |
Why?
|
Crack Cocaine | 1 | 2017 | 33 | 0.580 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2020 | 672 | 0.550 |
Why?
|
Activins | 2 | 2009 | 211 | 0.540 |
Why?
|
Eukaryotic Initiation Factor-2B | 1 | 2016 | 9 | 0.540 |
Why?
|
Drug Resistance, Viral | 2 | 2018 | 869 | 0.500 |
Why?
|
Ovarian Diseases | 1 | 2016 | 137 | 0.480 |
Why?
|
Dementia | 4 | 2024 | 2723 | 0.470 |
Why?
|
Nervous System Diseases | 2 | 2022 | 1668 | 0.460 |
Why?
|
Renal Artery Obstruction | 1 | 2015 | 218 | 0.450 |
Why?
|
Encephalitis | 3 | 2022 | 441 | 0.450 |
Why?
|
Cocaine-Related Disorders | 1 | 2017 | 461 | 0.450 |
Why?
|
Immune Evasion | 1 | 2017 | 377 | 0.440 |
Why?
|
Leukoencephalopathies | 1 | 2016 | 261 | 0.420 |
Why?
|
Vasospasm, Intracranial | 1 | 2015 | 215 | 0.420 |
Why?
|
Apolipoprotein E4 | 1 | 2016 | 712 | 0.390 |
Why?
|
HIV-1 | 6 | 2023 | 6966 | 0.390 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1891 | 0.380 |
Why?
|
HIV | 1 | 2018 | 1596 | 0.370 |
Why?
|
Autopsy | 4 | 2023 | 1013 | 0.370 |
Why?
|
Meningitis | 2 | 2022 | 219 | 0.350 |
Why?
|
Depression | 2 | 2021 | 8235 | 0.330 |
Why?
|
Cognition Disorders | 1 | 2023 | 3985 | 0.320 |
Why?
|
Brain | 11 | 2023 | 27438 | 0.310 |
Why?
|
Skin Diseases | 1 | 2017 | 1099 | 0.310 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2017 | 2203 | 0.310 |
Why?
|
Metagenomics | 3 | 2021 | 476 | 0.290 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 440 | 0.290 |
Why?
|
Confusion | 2 | 2020 | 278 | 0.270 |
Why?
|
Cerebrospinal Fluid | 2 | 2020 | 545 | 0.270 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 682 | 0.270 |
Why?
|
Central Nervous System | 6 | 2022 | 1348 | 0.260 |
Why?
|
Hypoxia, Brain | 1 | 2006 | 139 | 0.260 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2009 | 488 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3116 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.250 |
Why?
|
Lipids | 1 | 2016 | 3346 | 0.240 |
Why?
|
Inflammation | 3 | 2021 | 10865 | 0.240 |
Why?
|
Alleles | 1 | 2016 | 6890 | 0.240 |
Why?
|
Psychotic Disorders | 1 | 2020 | 3278 | 0.240 |
Why?
|
Depressive Disorder | 1 | 2017 | 3738 | 0.230 |
Why?
|
Paraparesis, Tropical Spastic | 1 | 2023 | 32 | 0.220 |
Why?
|
Enzyme Activation | 1 | 2009 | 3594 | 0.220 |
Why?
|
Humans | 56 | 2024 | 768451 | 0.210 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2023 | 143 | 0.210 |
Why?
|
Anti-HIV Agents | 2 | 2018 | 4567 | 0.210 |
Why?
|
CD4 Lymphocyte Count | 3 | 2018 | 2596 | 0.210 |
Why?
|
Reperfusion Injury | 1 | 2009 | 1034 | 0.210 |
Why?
|
Encephalitis, Varicella Zoster | 1 | 2022 | 7 | 0.200 |
Why?
|
Postural Orthostatic Tachycardia Syndrome | 1 | 2022 | 52 | 0.200 |
Why?
|
Viral Load | 4 | 2023 | 3399 | 0.190 |
Why?
|
Cognition | 5 | 2023 | 7066 | 0.190 |
Why?
|
Middle Aged | 27 | 2024 | 223418 | 0.190 |
Why?
|
Brain Neoplasms | 1 | 2023 | 9182 | 0.190 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2021 | 40 | 0.190 |
Why?
|
Herpesviridae Infections | 1 | 2022 | 269 | 0.190 |
Why?
|
Encephalitis Virus, California | 1 | 2020 | 9 | 0.190 |
Why?
|
Encephalitis, California | 1 | 2020 | 6 | 0.190 |
Why?
|
Ischemic Attack, Transient | 1 | 2006 | 878 | 0.180 |
Why?
|
Metagenome | 2 | 2021 | 465 | 0.180 |
Why?
|
Dehydroepiandrosterone | 1 | 2021 | 259 | 0.170 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 13026 | 0.170 |
Why?
|
Paresis | 1 | 2021 | 177 | 0.170 |
Why?
|
Brain Injuries | 2 | 2022 | 2060 | 0.170 |
Why?
|
Herpes Zoster | 1 | 2022 | 253 | 0.170 |
Why?
|
Speech Disorders | 1 | 2020 | 180 | 0.160 |
Why?
|
Exanthema | 1 | 2023 | 504 | 0.160 |
Why?
|
Frontotemporal Dementia | 1 | 2021 | 249 | 0.150 |
Why?
|
Policy | 1 | 2022 | 515 | 0.150 |
Why?
|
Male | 30 | 2024 | 364781 | 0.150 |
Why?
|
Neurocysticercosis | 1 | 2019 | 91 | 0.150 |
Why?
|
Pituitary-Adrenal System | 1 | 2021 | 557 | 0.150 |
Why?
|
Viruses | 1 | 2021 | 373 | 0.140 |
Why?
|
Encephalitis, Tick-Borne | 1 | 2018 | 45 | 0.140 |
Why?
|
Encephalitis Viruses, Tick-Borne | 1 | 2018 | 48 | 0.140 |
Why?
|
Peripheral Nerves | 1 | 2021 | 492 | 0.140 |
Why?
|
Chemokines | 1 | 2021 | 963 | 0.140 |
Why?
|
Herpesvirus 1, Human | 1 | 2022 | 744 | 0.140 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2021 | 705 | 0.140 |
Why?
|
Fatigue | 2 | 2022 | 1556 | 0.140 |
Why?
|
Neurofilament Proteins | 1 | 2019 | 337 | 0.140 |
Why?
|
Female | 26 | 2024 | 396943 | 0.130 |
Why?
|
Microvessels | 1 | 2021 | 586 | 0.130 |
Why?
|
Pancytopenia | 1 | 2017 | 102 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 7 | 2022 | 36840 | 0.130 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2017 | 133 | 0.130 |
Why?
|
Immunoglobulin M | 1 | 2021 | 1529 | 0.130 |
Why?
|
Frail Elderly | 1 | 2021 | 774 | 0.130 |
Why?
|
Adult | 17 | 2023 | 223542 | 0.130 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2021 | 1903 | 0.120 |
Why?
|
Blood-Brain Barrier | 1 | 2021 | 1034 | 0.120 |
Why?
|
Anti-Retroviral Agents | 2 | 2022 | 1794 | 0.120 |
Why?
|
Retrospective Studies | 10 | 2023 | 81834 | 0.120 |
Why?
|
Severity of Illness Index | 3 | 2022 | 15965 | 0.120 |
Why?
|
Sarcoma, Kaposi | 1 | 2017 | 374 | 0.110 |
Why?
|
Aged | 16 | 2024 | 171520 | 0.110 |
Why?
|
Diabetes Complications | 1 | 2020 | 1322 | 0.110 |
Why?
|
Heart Rate | 2 | 2022 | 4218 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 4586 | 0.110 |
Why?
|
Hydrocortisone | 1 | 2021 | 1836 | 0.110 |
Why?
|
Inflammation Mediators | 1 | 2022 | 1892 | 0.110 |
Why?
|
Genotype | 2 | 2018 | 13047 | 0.100 |
Why?
|
Antibodies, Viral | 2 | 2021 | 3212 | 0.100 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1408 | 0.100 |
Why?
|
Brain Diseases | 1 | 2022 | 1553 | 0.100 |
Why?
|
Methotrexate | 1 | 2019 | 1722 | 0.100 |
Why?
|
Occupational Diseases | 1 | 2021 | 1494 | 0.100 |
Why?
|
Prospective Studies | 7 | 2021 | 54914 | 0.100 |
Why?
|
Gastrointestinal Diseases | 1 | 2021 | 1207 | 0.100 |
Why?
|
Carcinoma, Basal Cell | 1 | 2017 | 564 | 0.100 |
Why?
|
Proteomics | 2 | 2022 | 3901 | 0.100 |
Why?
|
Cerebrovascular Circulation | 1 | 2022 | 2737 | 0.100 |
Why?
|
Herpesvirus 3, Human | 2 | 2022 | 159 | 0.090 |
Why?
|
Homozygote | 1 | 2016 | 1779 | 0.090 |
Why?
|
Neurons | 2 | 2009 | 9504 | 0.090 |
Why?
|
Brain Abscess | 1 | 2012 | 123 | 0.090 |
Why?
|
Frontal Lobe | 1 | 2017 | 1427 | 0.090 |
Why?
|
Injections, Intraventricular | 1 | 2009 | 227 | 0.080 |
Why?
|
Disease Susceptibility | 1 | 2016 | 1797 | 0.080 |
Why?
|
Blood Pressure | 2 | 2022 | 8538 | 0.080 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2012 | 342 | 0.080 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2723 | 0.080 |
Why?
|
Immunoglobulin G | 1 | 2021 | 4572 | 0.080 |
Why?
|
Risk Factors | 4 | 2023 | 74915 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3665 | 0.080 |
Why?
|
United States | 7 | 2024 | 73121 | 0.080 |
Why?
|
Electroencephalography | 2 | 2021 | 6309 | 0.080 |
Why?
|
Neuropsychological Tests | 2 | 2021 | 7134 | 0.080 |
Why?
|
Blood Gas Analysis | 1 | 2009 | 384 | 0.080 |
Why?
|
Neurology | 1 | 2016 | 786 | 0.080 |
Why?
|
Seizures | 1 | 2021 | 2996 | 0.070 |
Why?
|
Health Personnel | 1 | 2021 | 3384 | 0.070 |
Why?
|
Mutation, Missense | 1 | 2016 | 2594 | 0.070 |
Why?
|
Cytokines | 1 | 2021 | 7449 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4213 | 0.070 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4984 | 0.060 |
Why?
|
Weight Loss | 1 | 2017 | 2710 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20762 | 0.060 |
Why?
|
Phenotype | 1 | 2023 | 16712 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2019 | 14766 | 0.060 |
Why?
|
Stroke | 2 | 2023 | 9791 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2021 | 22293 | 0.050 |
Why?
|
Pandemics | 2 | 2020 | 8753 | 0.050 |
Why?
|
Hydrogen Peroxide | 1 | 2006 | 742 | 0.050 |
Why?
|
ROC Curve | 2 | 2021 | 3624 | 0.050 |
Why?
|
Proteome | 2 | 2022 | 1881 | 0.050 |
Why?
|
Dysgeusia | 1 | 2022 | 15 | 0.050 |
Why?
|
Orthostatic Intolerance | 1 | 2022 | 22 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8721 | 0.050 |
Why?
|
Proviruses | 1 | 2023 | 320 | 0.050 |
Why?
|
Lung | 1 | 2020 | 10090 | 0.050 |
Why?
|
Schizophrenia | 1 | 2020 | 6986 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 4861 | 0.050 |
Why?
|
Herpesvirus 2, Human | 1 | 2022 | 191 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2009 | 6242 | 0.050 |
Why?
|
Mental Disorders | 1 | 2021 | 6879 | 0.050 |
Why?
|
Basal Ganglia | 1 | 2023 | 555 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2017 | 4453 | 0.040 |
Why?
|
Young Adult | 2 | 2018 | 60045 | 0.040 |
Why?
|
Microglia | 1 | 2009 | 1376 | 0.040 |
Why?
|
Limit of Detection | 1 | 2021 | 277 | 0.040 |
Why?
|
Hypertension | 1 | 2020 | 8611 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15460 | 0.040 |
Why?
|
Unconsciousness | 1 | 2022 | 251 | 0.040 |
Why?
|
Disease Progression | 1 | 2017 | 13655 | 0.040 |
Why?
|
Age Factors | 1 | 2016 | 18478 | 0.040 |
Why?
|
Aging | 3 | 2024 | 8761 | 0.040 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2022 | 269 | 0.040 |
Why?
|
Animals | 3 | 2023 | 169418 | 0.040 |
Why?
|
Intracranial Hemorrhages | 1 | 2023 | 815 | 0.040 |
Why?
|
Up-Regulation | 1 | 2006 | 4138 | 0.040 |
Why?
|
Muscular Diseases | 1 | 2022 | 555 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10784 | 0.040 |
Why?
|
Autonomic Nervous System | 1 | 2022 | 709 | 0.040 |
Why?
|
Intensive Care Units | 2 | 2021 | 3805 | 0.040 |
Why?
|
Quality-Adjusted Life Years | 1 | 2024 | 1734 | 0.030 |
Why?
|
Life Expectancy | 1 | 2024 | 1249 | 0.030 |
Why?
|
Cell Survival | 1 | 2006 | 5801 | 0.030 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2022 | 716 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14728 | 0.030 |
Why?
|
Electronic Health Records | 2 | 2023 | 4877 | 0.030 |
Why?
|
HIV Antibodies | 1 | 2022 | 1341 | 0.030 |
Why?
|
Europe | 1 | 2022 | 3439 | 0.030 |
Why?
|
Cohort Studies | 3 | 2022 | 41797 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2021 | 1397 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39430 | 0.030 |
Why?
|
Memory Disorders | 1 | 2022 | 1204 | 0.030 |
Why?
|
Genome, Viral | 1 | 2018 | 673 | 0.030 |
Why?
|
Headache | 1 | 2022 | 1260 | 0.030 |
Why?
|
Natural Language Processing | 1 | 2022 | 1197 | 0.030 |
Why?
|
Marijuana Abuse | 1 | 2017 | 412 | 0.030 |
Why?
|
Rats | 1 | 2009 | 23839 | 0.030 |
Why?
|
Liver Diseases | 1 | 2021 | 1307 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1607 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2022 | 6091 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2020 | 1359 | 0.030 |
Why?
|
Propionibacterium acnes | 1 | 2012 | 59 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2006 | 12813 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2017 | 15638 | 0.020 |
Why?
|
Mice | 2 | 2009 | 82045 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2006 | 19041 | 0.020 |
Why?
|
Survival Analysis | 1 | 2023 | 10125 | 0.020 |
Why?
|
Hospitalization | 2 | 2021 | 10845 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2006 | 5827 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18388 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2022 | 1876 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2021 | 3590 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8730 | 0.020 |
Why?
|
Computer Simulation | 1 | 2022 | 6278 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2018 | 1600 | 0.020 |
Why?
|
Critical Care | 1 | 2020 | 2717 | 0.020 |
Why?
|
Critical Illness | 1 | 2021 | 2754 | 0.020 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2012 | 1051 | 0.020 |
Why?
|
Time Factors | 1 | 2009 | 40271 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59680 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10601 | 0.020 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3246 | 0.020 |
Why?
|
Sleep | 1 | 2021 | 4796 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 21552 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2022 | 6657 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20231 | 0.010 |
Why?
|
Prevalence | 1 | 2021 | 15880 | 0.010 |
Why?
|
Medicare | 1 | 2022 | 6881 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5887 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6320 | 0.010 |
Why?
|
Algorithms | 1 | 2022 | 14158 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 30028 | 0.010 |
Why?
|
Mutation | 1 | 2023 | 30243 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 26351 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 65409 | 0.010 |
Why?
|